23 May 2013
Keywords: allergan, buys, esprit, pharma, 370m, cash, drugmaker
Article | 27 September 2007
US drugmaker Allergan has acquired fellow USA-based Esprit Pharma for $370.0 million in an all-cash deal. Esprit is a drugmaker with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.